The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Krill Steven L. since 2015.
The trader's CIK number is 1599743.
At the time of the last reporting, Krill Steven L. was the Chief Scientific Officer of Eagle Pharmaceuticals, Inc.. (stock ticker symbol EGRX).
Also see all insider trading activities at Eagle Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | EGRX | 0 | $0 | 64,630 | $5,003,766 | 64,630 | $1,261,343 |
| 2016 | EGRX | 0 | $0 | 15,987 | $1,215,120 | 15,987 | $88,356 |
| 2015 | EGRX | 0 | $0 | 9,980 | $814,368 | 9,980 | $73,123 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-03-22 | EGRX | Option Ex | 7,100 | 8.54 | 60,669 |
| 2017-03-23 | EGRX | Option Ex | 7,025 | 12.65 | 88,866 |
| 2017-03-22 | EGRX | Sale | 7,100 | 80.09 | 568,639 |
| 2017-03-23 | EGRX | Sale | 7,025 | 82.06 | 576,492 |
| 2016-12-15 | EGRX | Option Ex | 10,000 | 8.54 | 85,450 |
| 2016-12-23 | EGRX | Sale | 5,127 | 78.61 | 403,018 |
| 2016-12-22 | EGRX | Sale | 5,126 | 76.78 | 393,569 |
| 2016-12-19 | EGRX | Sale | 10,000 | 75.61 | 756,070 |
| 2016-12-21 | EGRX | Sale | 10,252 | 77.17 | 791,198 |
| 2016-12-20 | EGRX | Sale | 10,000 | 76.69 | 766,880 |
| 2016-12-15 | EGRX | Sale | 10,000 | 74.79 | 747,900 |
| 2016-12-20 | EGRX | Option Ex | 10,000 | 12.63 | 126,300 |
| 2016-12-21 | EGRX | Option Ex | 10,252 | 29.36 | 300,998 |
| 2016-12-19 | EGRX | Option Ex | 10,000 | 12.65 | 126,500 |
| 2016-12-22 | EGRX | Option Ex | 5,126 | 46.09 | 236,257 |
| 2016-12-23 | EGRX | Option Ex | 5,127 | 46.09 | 236,303 |
| 2016-12-13 | EGRX | Sale | 10,000 | 73.62 | 736,160 |
| 2016-12-13 | EGRX | Option Ex | 10,000 | 4.42 | 44,200 |
| 2016-11-30 | EGRX | Option Ex | 5,787 | 7.33 | 42,401 |
| 2016-11-23 | EGRX | Sale | 200 | 80.00 | 16,000 |
| 2016-11-23 | EGRX | Option Ex | 200 | 8.78 | 1,755 |
| 2016-11-30 | EGRX | Sale | 5,787 | 80.00 | 462,960 |
| 2015-06-16 | EGRX | Option Ex | 9,980 | 7.33 | 73,123 |
| 2015-06-16 | EGRX | Sale | 9,980 | 81.60 | 814,368 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Krill Steven L. (Chief Scientific Officer of Eagle Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.